
In a real-world cohort of >44,000 adults with BMI ≥35, sleeve gastrectomy and gastric bypass achieved ~22–30% total weight loss at 2–3 years, vs ~7–12% with semaglutide/tirzepatide, even with continuous GLP-1RA use. Bariatric surgery remains the most effective durable option for patients eligible for both. onlinelibrary.wiley.com/doi/abs/10.100…






















